Home/Filings/4/0001214659-20-000769
4//SEC Filing

CHEN ISAN 4

Accession 0001214659-20-000769

CIK 0001576263other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 8:03 PM ET

Size

7.2 KB

Accession

0001214659-20-000769

Insider Transaction Report

Form 4
Period: 2020-01-29
CHEN ISAN
Chief Medical & Dev't Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2020-01-29$24.99/sh+3,002$75,02039,401 total
  • Exercise/Conversion

    Stock Options

    2020-01-293,00256,754 total
    Exercise: $24.99Exp: 2026-01-21Common Stock (3,002 underlying)
Footnotes (2)
  • [F1]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.
  • [F2]Includes 392 shares acquired under the ESPP Purchase on 05/31/2019 and 171 shares acquired under the ESPP purchase on 11/29/2019.

Issuer

Mirati Therapeutics, Inc.

CIK 0001576263

Entity typeother

Related Parties

1
  • filerCIK 0001586218

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 8:03 PM ET
Size
7.2 KB